Browsing Tag
American Urological Association
5 posts
CG Oncology reports best-in-disease durability data for cretostimogene at AUA 2025
Find out how CG Oncology's cretostimogene data is redefining bladder cancer treatment with best-in-disease durability and strong safety at AUA 2025!
Zenflow says Spring Device delivered sustained benefits and safety in long-term BPH study
Discover how Zenflow’s Spring System is redefining BPH treatment with durable, three-year benefits and paving the way for FDA approval and commercial launch!
Johnson & Johnson’s TAR-200 delivers over 80% disease-free survival, offering new hope in BCG-unresponsive high-risk papillary NMIBC
Discover how Johnson & Johnson’s TAR-200 is redefining bladder cancer treatment with over 80% disease-free survival and 94% bladder preservation today!
Pfizer breakthrough: New immunotherapy combo slashes bladder cancer recurrence risk by 32%
Discover how Pfizer’s new sasanlimab combination therapy is redefining treatment for high-risk bladder cancer after 30 years — read the breakthrough results now!
Breakthrough for recurrent bladder cancer: UroGen’s UGN-102 achieves 80.6% 18-month complete response in phase 3 trial
Discover how UroGen Pharma’s UGN-102 could transform bladder cancer treatment with durable results; find out what the Phase 3 ENVISION trial reveals!